Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization

Takaaki Yoshimura,Ryota Yamada,Rumiko Kinoshita,Taeko Matsuura,Takahiro Kanehira,Hiroshi Tamura,Kentaro Nishioka,Koichi Yasuda,Hiroshi Taguchi,Norio Katoh,Keiji Kobashi,Takayuki Hashimoto,Hidefumi Aoyama

DOI: https://doi.org/10.1093/jrr/rrae008

2024-03-17

Journal of Radiation Research

Abstract:Abstract This retrospective treatment-planning study was conducted to determine whether intensity-modulated proton therapy with robust optimization (ro-IMPT) reduces the risk of acute hematologic toxicity (H-T) and acute and late gastrointestinal toxicity (GI-T) in postoperative whole pelvic radiotherapy for gynecologic malignancies when compared with three-dimensional conformal radiation therapy (3D-CRT), intensity-modulated X-ray (IMXT) and single-field optimization proton beam (SFO-PBT) therapies. All plans were created for 13 gynecologic-malignancy patients. The prescribed dose was 45 GyE in 25 fractions for 95% planning target volume in 3D-CRT, IMXT and SFO-PBT plans and for 99% clinical target volume (CTV) in ro-IMPT plans. The normal tissue complication probability (NTCP) of each toxicity was used as an in silico surrogate marker. Median estimated NTCP values for acute H-T and acute and late GI-T were 0.20, 0.94 and 0.58 × 10−1 in 3D-CRT; 0.19, 0.65 and 0.24 × 10−1 in IMXT; 0.04, 0.74 and 0.19 × 10−1 in SFO-PBT; and 0.06, 0.66 and 0.15 × 10−1 in ro-IMPT, respectively. Compared with 3D-CRT and IMXT plans, the ro-IMPT plan demonstrated significant reduction in acute H-T and late GI-T. The risk of acute GI-T in ro-IMPT plan is equivalent with IMXT plan. The ro-IMPT plan demonstrated potential clinical benefits for reducing the risk of acute H-T and late GI-T in the treatment of gynecologic malignances by reducing the dose to the bone marrow and bowel bag while maintaining adequate dose coverage to the CTV. Our results indicated that ro-IMPT may reduce acute H-T and late GI-T risk with potentially improving outcomes for postoperative gynecologic-malignancy patients with concurrent chemotherapy.

oncology,radiology, nuclear medicine & medical imaging,biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether the use of intensity - modulated proton therapy with robust optimization (ro - IMPT) can reduce the risks of acute hematotoxicity (H - T) and acute and late gastrointestinal toxicity (GI - T) in whole - pelvic radiotherapy after gynecological malignancies surgery, compared with three - dimensional conformal radiotherapy (3D - CRT), intensity - modulated X - ray therapy (IMXT) and single - field - optimized proton beam therapy (SFO - PBT).

Specifically, through a retrospective treatment planning study, the researchers compared the dose distributions and normal tissue complication probabilities (NTCP) of different radiotherapy techniques in 13 patients with gynecological malignancies to assess the risk of each toxicity type. The main objective of the study was to determine whether ro - IMPT can effectively reduce the irradiated doses of bone marrow and intestinal pouches without sacrificing the target area dose coverage, thereby reducing the risks of acute H - T and late GI - T.

The research results show that, compared with 3D - CRT and IMXT plans, the ro - IMPT plan significantly reduces the risks of acute H - T and late GI - T. Although the acute GI - T risk in the ro - IMPT plan is comparable to that in the IMXT plan, it shows potential clinical advantages in reducing the risks of acute H - T and late GI - T. This indicates that ro - IMPT may improve the treatment outcomes of patients receiving concurrent chemotherapy after gynecological malignancies surgery by reducing the doses of bone marrow and intestinal pouches.